Trial Profile
Evaluating Teriparatide as a Chondroregenerative Therapy in Human Osteoarthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Oct 2022
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- 17 Oct 2022 Status changed from active, no longer recruiting to completed.
- 20 Jan 2022 Planned primary completion date changed from 1 Oct 2021 to 1 Oct 2022.
- 03 Nov 2020 Planned End Date changed from 1 Oct 2021 to 1 Oct 2022.